- Home
- SMID vs FENC Comparison
SMID vs FENC Comparison
Compare SMID & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMID
- FENC
- Stock Information
- Founded
- SMID 1960
- FENC 1996
- Country
- SMID United States
- FENC United States
- Employees
- SMID N/A
- FENC N/A
- Industry
- SMID Building Materials
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SMID Industrials
- FENC Health Care
- Exchange
- SMID Nasdaq
- FENC Nasdaq
- Market Cap
- SMID 166.5M
- FENC 145.9M
- IPO Year
- SMID 1995
- FENC 2001
- Fundamental
- Price
- SMID $45.91
- FENC $6.23
- Analyst Decision
- SMID
- FENC Strong Buy
- Analyst Count
- SMID 0
- FENC 2
- Target Price
- SMID N/A
- FENC $14.00
- AVG Volume (30 Days)
- SMID 28.6K
- FENC 182.2K
- Earning Date
- SMID 11-14-2024
- FENC 11-07-2024
- Dividend Yield
- SMID N/A
- FENC N/A
- EPS Growth
- SMID 1025.92
- FENC N/A
- EPS
- SMID 1.22
- FENC N/A
- Revenue
- SMID $76,366,000.00
- FENC $49,348,000.00
- Revenue This Year
- SMID N/A
- FENC $97.94
- Revenue Next Year
- SMID N/A
- FENC $11.50
- P/E Ratio
- SMID $41.02
- FENC N/A
- Revenue Growth
- SMID 32.40
- FENC 278.09
- 52 Week Low
- SMID $25.03
- FENC $3.96
- 52 Week High
- SMID $51.96
- FENC $11.92
- Technical
- Relative Strength Index (RSI)
- SMID 62.38
- FENC 73.11
- Support Level
- SMID $45.17
- FENC $5.80
- Resistance Level
- SMID $46.20
- FENC $6.46
- Average True Range (ATR)
- SMID 3.50
- FENC 0.47
- MACD
- SMID 0.57
- FENC 0.20
- Stochastic Oscillator
- SMID 66.37
- FENC 87.71
About SMID Smith-Midland Corporation
Smith-Midland Corp through its subsidiaries invents, develops, manufactures, markets, sells, and installs precast concrete products for primary use in the construction, highway, utilities, and farming industries. The firm's customers are general contractors and federal, state, and local transportation authorities. Its products include Slenderwall, JJhooks, Softsound, Sierra Wall and Easi set. A substantial portion of the company's business is derived from local, state, and federal building projects. The company generates revenues predominantly from the sale, leasing, licensing, shipping, and installation of precast concrete products for the construction, utility, and farming industries.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.